291 related articles for article (PubMed ID: 36002198)
1. [Research Progress on the Application of Liquid Biopsy in the Diagnosis
and Treatment of Small Cell Lung Cancer].
Zhang X; Xu M; Li X; Su Y
Zhongguo Fei Ai Za Zhi; 2022 Aug; 25(8):609-614. PubMed ID: 36002198
[TBL] [Abstract][Full Text] [Related]
2. Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy?
Fasano R; Serratì S; Rafaschieri T; Longo V; Di Fonte R; Porcelli L; Azzariti A
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672414
[TBL] [Abstract][Full Text] [Related]
3. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring.
Li W; Liu JB; Hou LK; Yu F; Zhang J; Wu W; Tang XM; Sun F; Lu HM; Deng J; Bai J; Li J; Wu CY; Lin QL; Lv ZW; Wang GR; Jiang GX; Ma YS; Fu D
Mol Cancer; 2022 Jan; 21(1):25. PubMed ID: 35057806
[TBL] [Abstract][Full Text] [Related]
4. Liquid Biopsy in Small Cell Lung Cancer-A Route to Improved Clinical Care?
Church M; Carter L; Blackhall F
Cells; 2020 Dec; 9(12):. PubMed ID: 33287165
[TBL] [Abstract][Full Text] [Related]
5. Will liquid biopsies improve outcomes for patients with small-cell lung cancer?
Blackhall F; Frese KK; Simpson K; Kilgour E; Brady G; Dive C
Lancet Oncol; 2018 Sep; 19(9):e470-e481. PubMed ID: 30191851
[TBL] [Abstract][Full Text] [Related]
6. [Advances in Clinical Application of Liquid Biopsy in Non-small Cell Lung Cancer].
Zhang M; Chen J
Zhongguo Fei Ai Za Zhi; 2021 Oct; 24(10):723-728. PubMed ID: 34696544
[TBL] [Abstract][Full Text] [Related]
7. Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment.
Messaritakis I; Nikolaou M; Koinis F; Politaki E; Koutsopoulos A; Lagoudaki E; Vetsika EK; Georgoulias V; Kotsakis A
Lung Cancer; 2019 Sep; 135():33-39. PubMed ID: 31447000
[TBL] [Abstract][Full Text] [Related]
8. The predictive and prognostic significance of liquid biopsy in advanced epidermal growth factor receptor-mutated non-small cell lung cancer: A prospective study.
Ding PN; Becker TM; Bray VJ; Chua W; Ma YF; Lynch D; Po J; Luk AWS; Caixeiro N; de Souza P; Roberts TL
Lung Cancer; 2019 Aug; 134():187-193. PubMed ID: 31319980
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy in breast cancer: A comprehensive review.
Alimirzaie S; Bagherzadeh M; Akbari MR
Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
[TBL] [Abstract][Full Text] [Related]
10. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
[No Abstract] [Full Text] [Related]
11. Liquid biopsy = Individualized cancer management: Diagnosis, monitoring treatment and checking recurrence and metastasis.
Mali SB; Dahivelkar S
Oral Oncol; 2021 Dec; 123():105588. PubMed ID: 34744021
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy tracking of lung tumor evolutions over time.
Russo A; De Miguel Perez D; Gunasekaran M; Scilla K; Lapidus R; Cooper B; Mehra R; Adamo V; Malapelle U; Rolfo C
Expert Rev Mol Diagn; 2019 Dec; 19(12):1099-1108. PubMed ID: 31608732
[No Abstract] [Full Text] [Related]
13. Liquid biopsy in ovarian cancer.
Giannopoulou L; Lianidou ES
Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
[TBL] [Abstract][Full Text] [Related]
14. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers.
Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L
Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755
[TBL] [Abstract][Full Text] [Related]
15. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.
Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R
Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770
[TBL] [Abstract][Full Text] [Related]
16. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
Ye Q; Ling S; Zheng S; Xu X
Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy for early diagnosis of non-small cell lung carcinoma: recent research and detection technologies.
Chang L; Li J; Zhang R
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188729. PubMed ID: 35436521
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor DNA as liquid biopsy in lung cancer: Biological characteristics and clinical integration.
Li C; Shao J; Li P; Feng J; Li J; Wang C
Cancer Lett; 2023 Nov; 577():216365. PubMed ID: 37634743
[TBL] [Abstract][Full Text] [Related]
19. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
20. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
